Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 71Colorectal Neoplasms 34Rectal Neoplasms 33Esophageal Neoplasms 25Carcinoma, Non-Small-Cell Lung 24Esophageal Squamous Cell Carcinoma 23Pancreatic Neoplasms 16Stomach Neoplasms 15Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Adenocarcinoma Of Esophagus 14Sarcoma 11Ovarian Neoplasms 11Lung Neoplasms 11Colonic Neoplasms 11Carcinoma, Hepatocellular 11Prostatic Neoplasms 10Head and Neck Neoplasms 10Neoplasm Metastasis 9Urinary Bladder Neoplasms 8Uterine Cervical Neoplasms 7Recurrence 6Osteosarcoma 6Multiple Myeloma 5Fallopian Tube Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Breast Carcinoma In Situ 5Peritoneal Neoplasms 4Nasopharyngeal Carcinoma 4Locally Advanced Rectal Cancer 4

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Neoadjuvant Therapy 1Fluorouracil 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoadjuvant Chemotherapy × Neoadjuvant Therapy × Clear all
NCT06151379 2023-11-30

Muscle Parameters and Pathological Response in Breast Cancer Patients

Acıbadem Atunizade Hospital

Completed
69 enrolled

Neoadjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡